Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

FDA 510(k)

Tissue of Origin Test Kit-FFPE

N.º K: K173839 · 2018-03-15

SolicitanteCancer Genetics, Inc.
Fecha de decisión2018-03-15
Código de productoOIW
Comité asesorTX
DecisiónSubstantially Equivalent

Resumen del dispositivo

Tissue of Origin Test Kit-FFPE is the device name listed in this FDA 510(k) record. The listed applicant is Cancer Genetics, Inc.. It received FDA 510(k) clearance on 2018-03-15 under 510(k) number K173839. The device is classified under product code OIW. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the Tissue of Origin Test Kit-FFPE?

Tissue of Origin Test Kit-FFPE is a medical device that received FDA 510(k) clearance on 2018-03-15. The listed applicant is Cancer Genetics, Inc.. The 510(k) number is K173839.

When did Tissue of Origin Test Kit-FFPE receive FDA 510(k) clearance?

Tissue of Origin Test Kit-FFPE received FDA 510(k) clearance on 2018-03-15, under 510(k) number K173839.

Who is the listed applicant for Tissue of Origin Test Kit-FFPE?

The FDA 510(k) record lists Cancer Genetics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Tissue of Origin Test Kit-FFPE?

The FDA product code for Tissue of Origin Test Kit-FFPE is OIW.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑